
Cardiac Amyloidosis
- Publisher's listprice EUR 160.49
-
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 13 616 Ft off)
- Discounted price 54 463 Ft (51 870 Ft + 5% VAT)
68 079 Ft
Availability
Not yet published.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Springer
- Date of Publication 25 June 2025
- Number of Volumes 1 pieces, Book
- ISBN 9783031883415
- Binding Hardback
- No. of pages596 pages
- Size 235x155 mm
- Language English
- Illustrations 8 Illustrations, black & white; 105 Illustrations, color 700
Categories
Short description:
This book reviews the diagnosis and management of cardiac amyloidosis. Systemic amyloidosis is a broad spectrum of diseases that results from misfolding of proteins that aggregate into amyloid fibrils. In cardiac amyloidosis, amyloid fibrils accumulate in the interstitial space between cardiac myocytes causing cellular injury and impairing cardiac function.
Cardiac Amyloidosis reviews the advances in cardiac imaging, diagnostic strategies and therapies available that have improved the recognition and treatment of cardiac amyloidosis. The contributors to this book have distilled the existing clinical guidelines into a novel and simple pathway to help healthcare providers diagnose and treat patients. Within this book they review each section of this pathway: suspicion, red flags, diagnosis, treatment and follow up. With current data suggesting that cardiac amyloidosis is more common than previously thought, this book is a timely addition to the literature and will be important for all healthcare professionals managing these patients.
Long description:
This book reviews the diagnosis and management of cardiac amyloidosis. Systemic amyloidosis is a broad spectrum of diseases that results from misfolding of proteins that aggregate into amyloid fibrils. In cardiac amyloidosis, amyloid fibrils accumulate in the interstitial space between cardiac myocytes causing cellular injury and impairing cardiac function.
Cardiac Amyloidosis reviews the advances in cardiac imaging, diagnostic strategies and therapies available that have improved the recognition and treatment of cardiac amyloidosis. The contributors to this book have distilled the existing clinical guidelines into a novel and simple pathway to help healthcare providers diagnose and treat patients. Within this book they review each section of this pathway: suspicion, red flags, diagnosis, treatment and follow up. With current data suggesting that cardiac amyloidosis is more common than previously thought, this book is a timely addition to the literature and will be important for all healthcare professionals managing these patients.
Table of Contents:
Pathway for the diagnosis and management of CA.- Epidemiology and pathophysiology of CA.- Diagnosis of CA- ECG.- Diagnosis of CA- Echocardiography.- Diagnosis of CA- Nuclear imaging.- Diagnosis of CA- CMR.- Diagnosis of CA- Hematological testing.- Genetics testing in CA. Treatment of CA- heart failure.- Treatment of CA- Advanced heart failure management.- Treatment of CA- arrythmias management.- Treatment of CA- aortic stenosis management.- Treatment of CA- Disease modifying therapies.- Treatment of CA- New frontier and evolving therapies.- Hematological manifestations and treatment.- Neurology and CA.- Gastroenterology and CA.- Nephrology and CA.- Follow up of patients with CA.- Prognosis of patients with CA.- Case presentation of patients with CA using the CA pathway.
More
Cardiac Amyloidosis
Subcribe now and receive a favourable price.
Subscribe
68 079 HUF